Changes in liver stiffness and steatosis among patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response
Natsuko Kobayashi(Hyogo Medical University), Shuhei Nishiguchi(Osaka City General Hospital), Yoshiyuki Sakai(Hyogo Medical University), Jiro Fujimoto(Harvard University), Tomoyuki Takashima(Hyogo Medical University), Hirayuki Enomoto(Hyogo Medical University), Seiichi Hirota(Hyogo Medical University), Takashi Kumada(Gifu Kyoritsu University), Nobuhiro Aizawa(Hyogo Medical University), Hiroko Iijima(Hyogo University), Hiroki Nishikawa(Hyogo Medical University), Chikage Nakano(Hyogo Medical University), Takashi Nishimura(Hyogo University), Toshifumi Tada(Himeji Red Cross Hospital), Tomoko Aoki(Kindai University Hospital), Masahiro Yoshida(Toho University), Yoshinori Iwata(Hyogo Medical University), Kazunori Yoh(Hyogo Medical University), Akio Ishii, Naoto Ikeda(Hyogo Medical University), Ryo Takata
Cited by 56
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2011|713
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
|Oncogene|1999|693
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system
|International Immunology|2008|480
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346